In Vitro and In Vivo Antibacterial Activities of CS-834, a New Oral Carbapenem
CS-834 is a prodrug of the carbapenem R-95867, developed by Sankyo Co., Ltd., Tokyo, Japan. To investigate the possibility that CS-834 may be the first carbapenem usable in an oral dosage form, its in vitro antibacterial activity (as R-95867) and in vivo antibacterial activity were compared with tho...
Na minha lista:
| Udgivet i: | Antimicrob Agents Chemother |
|---|---|
| Principais autores: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society for Microbiology (ASM)
1998
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC105498/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9517932/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.42.3.555 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
